English | Español

Glaxosmithkline
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Carol Ostrow | Dec 16, 2017

Multiple myeloma study results encouraging, GSK says
Carol Ostrow | Dec 15, 2017

GSK receives FDA approval for expanded use of Nucala
Carol Ostrow | Dec 15, 2017

GSK says Shingrix promising for preventing shingles in stem cell transplant patients
Carol Ostrow | Sep 24, 2017

GlaxoSmithKline, Innoviva COPD therapy gains FDA approval
Carol Ostrow | Sep 23, 2017

Self-injectable form of Lupus therapy clears hurdle in Europe
Carol Ostrow | Sep 21, 2017

GSK’s Shingrix shingles vaccine clears an FDA hurdle

Carol Ostrow | Sep 18, 2017

Salford Lung Study shows promise for GlaxoSmithKline asthma treatment

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval